Description

BSE lists new Commercial Paper of Kotak Mahindra Prime Limited worth Rs. 50 crore on debt segment with maturity date of August 28, 2026.

Summary

BSE has listed new Commercial Paper issued by Kotak Mahindra Prime Limited on private placement basis with effect from October 23, 2025. The issue comprises 1,000 units of Rs. 5,00,000 each (total Rs. 50 crore) issued at a discount price of Rs. 4,72,783 per unit with maturity on August 28, 2026.

Key Points

  • Issuer: Kotak Mahindra Prime Limited
  • Instrument: Commercial Paper (Private Placement)
  • Quantity: 1,000 units
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,72,783 per unit (discount of Rs. 27,217)
  • Total Issue Size: Rs. 50 crore
  • Market Lot: 1 unit
  • Scrip Code: 730427
  • Scrip ID: KMPL231025
  • ISIN: INE916D145Z2
  • Credit Rating: CRISIL A1+, ICRA A1+
  • Trading Mode: Dematerialized form only
  • Issuing and Paying Agent: Kotak Mahindra Bank

Regulatory Changes

No regulatory changes announced. This is a standard debt instrument listing.

Compliance Requirements

  • Trading members must trade the securities only in dematerialized form under ISIN INE916D145Z2
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • Tick size for the securities is 1 paise
  • Trading members requiring clarification may contact BSE debt department on 22728352/8597/8995/5753/8915

Important Dates

  • Listing Date: October 23, 2025
  • Allotment Date: October 23, 2025
  • Maturity/Redemption Date: August 28, 2026
  • Tenor: Approximately 10 months

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The instrument provides short-term financing for Kotak Mahindra Prime Limited and offers institutional investors a highly-rated (A1+) debt investment option. The listing expands BSE’s debt segment offerings but has no direct impact on equity markets or trading members’ operations beyond providing an additional trading instrument.

Impact Justification

Routine debt instrument listing with no impact on equity markets or regulatory changes